// App-Quantinova.ai

: Comparison of Vital Status and Cause-Specific Mortality after Hematopoietic Cell Transplantation between the Center for International Blood and Marrow Transplant Research and the California Cancer Registry: A Record-Linkage Analysis from 1991 to 2018

Researchers

Presenter

  • Bryan Valcarcel

Principal Investigators

  • Sara J. Schonfeld

  • Christa L. Meyer

  • Ann M Brunson

  • Julianne J.P. Cooley

  • Renata Abrahao

  • Ted Wun

  • Jeffery Auletta

  • Lori Muffly

  • Theresa H.M. Keegan

  • Lindsay M. Morton

Medical Centers

  • California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA

  • Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA

  • Divisions of Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH

  • Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

  • CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN

  • Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved